A Novel MICB-Targeting CAR-NK Cells for the Treatment of Pancreatic Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27010500 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Weiyang Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Research Center for Biological Sciences, Ministry of Science and Technology, Shanghai Ocean University, Shanghai 201306, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Pancreatic Neoplasms, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nuclear (Shanghai) Pharmaceutical Technology Co., Ltd., the Science and Technology Commission of Shanghai Municipality, China.
Abstract (Originalsprache)
MICB-targeting CAR-NK (chimeric antigen receptor-modified natural killer cells) therapy may serve as off-the-shelf immunotherapy. We designed soluble Anti-MICB-scFv blocks tumor immune evasion targeting the MICB antigen, thereby enhancing CAR-NK cytotoxicity while reactivating endogenous immune attacks against malignancies. The Anti-MICB-CAR includes two Anti-MICB-scFv connected by an F2A linker, the CD8 hinge and transmembrane domain, the 4-1BB co-stimulatory domain, the CD3ζ activation domain, and IL-15. The expression efficiency of Anti-MICB-CAR in NK cells was investigated by flow cytometry; ELISA demonstrated that Anti-MICB-CAR-NK secreted free Anti-MICB-scFv and detected IL-15 secretion. Flow cytometry and CCK8 were utilized to study Anti-MICB-CAR-NK on tumor cell viability. The PANC-1 xenograft model was established in order to elucidate the anti-tumor effects of Anti-MICB-CAR-NK in vivo. In vitro investigations have demonstrated that the treatment of tumor cells with Anti-MICB-CAR-NK supernatant + NK cells or Anti-MICB-CAR-NK cells not only significantly increased the cytotoxic activity of tumor cells, but also secreted and produced higher levels of IL-15, IFN-γ, TNF-α, perforin, and granzyme B compared with NK cells. Anti-MICB-CAR-NK cells exhibit strong cytotoxic activity against tumor cells with high MICB expression. In vivo, Anti-MICB-CAR-NK cells exhibited a substantial inhibitory effect on tumor growth. The IHC results reveal that Anti-MICB-CAR-NK cells show a more pronounced ability to infiltrate the tumor. We demonstrated the successful expression of Anti-MICB-CAR in NK cells, which enhances the anti-tumor activity of NK cells both in vitro and in vivo. This stress ligand-targeting approach provides a promising strategy for solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Research Center for Biological Sciences, Ministry of Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
- Aquatic Animal Genetics and Breeding Center, Shanghai Ocean University, Shanghai 201306, China.
- National Aquatic Animal Pathogen Collection Center, Shanghai Ocean University, Shanghai 201306, China.
- Medical Research Center, Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310050, China.
- Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou 310013, China.
Förderung
- Nuclear (Shanghai) Pharmaceutical Technology Co., Ltd.
- the Science and Technology Commission of Shanghai Municipality, China
Zitieren
APA
Jin, W., Wang, M., Wang, J., Fan, J., Fang, J., & Yang, G. (2026). A Novel MICB-Targeting CAR-NK Cells for the Treatment of Pancreatic Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010500
Vancouver
Jin W, Wang M, Wang J, Fan J, Fang J, Yang G. A Novel MICB-Targeting CAR-NK Cells for the Treatment of Pancreatic Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27010500
BibTeX
@article{Jin2026,
author = {Jin, Weiyang and Wang, Mengying and Wang, Jingwei and Fan, Jinyi and Fang, Jie and Yang, Guanghua},
title = {A Novel MICB-Targeting CAR-NK Cells for the Treatment of Pancreatic Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27010500}
}
EUVIMED